Diabetes Care, Vol 23, Issue 11 1654-1659, Copyright © 2000 by American Diabetes Association

ARTICLES

Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis

GA Nichols, HS Glauber and JB Brown
Kaiser Permanente Center for Health Research, Portland, Oregon, USA. greg.nichols@kp.org

OBJECTIVE: To describe and analyze medical care costs for the 8 years preceding a diagnosis of type 2 diabetes. RESEARCH DESIGN AND METHODS: From electronic records of a large group-model health maintenance organization (HMO), we ascertained the medical care costs preceding diagnosis for all members with type 2 diabetes who were newly diagnosed between 1988 and 1995. To isolate incremental costs (costs caused by the future diagnosis of diabetes), we subtracted the costs of individually age- and sex-matched HMO members without impending diabetes from the costs of members who were destined to receive this diagnosis. We also compared these prediagnosis costs with the first 3 years of postdiagnosis costs. RESULTS: An economic burden from impending diabetes is apparent for at least 8 years before diagnosis, beginning with costs for outpatient and pharmacy services. Diabetes-associated incremental costs (costs of type 2 diabetic patients minus matched costs of nondiabetic patients) averaged $1,205 per type 2 diabetic patient per year during the first eight prediagnostic years, including $1,913 each year for the 3 years preceding diagnosis. In the year immediately preceding diagnosis, incremental costs were equivalent to those observed in the second and third years after diagnosis. CONCLUSIONS: Incremental costs of diabetes begin at least 8 years before diagnosis and grow at an accelerating rate as diagnosis approaches and immediately after diagnosis. These incremental costs span the full range of medical services. Furthermore, the majority of these costs are for conditions not normally associated with diabetes or its complications.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. G. Trogdon and T. Hylands Nationally Representative Medical Costs of Diabetes by Time Since Diagnosis Diabetes Care, December 1, 2008; 31(12): 2307 - 2311. [Abstract] [Full Text] [PDF]

				J. A. Johnson, S. L. Pohar, and S. R. Majumdar Health Care Use and Costs in the Decade After Identification of Type 1 and Type 2 Diabetes: A population-based study. Diabetes Care, November 1, 2006; 29(11): 2403 - 2408. [Abstract] [Full Text] [PDF]

				G. A. Nichols and J. B. Brown Higher Medical Care Costs Accompany Impaired Fasting Glucose Diabetes Care, September 1, 2005; 28(9): 2223 - 2229. [Abstract] [Full Text] [PDF]

				M. Pisu, N. James, S. Sampsel, and K. G. Saag The cost of glucocorticoid-associated adverse events in rheumatoid arthritis Rheumatology, June 1, 2005; 44(6): 781 - 788. [Abstract] [Full Text] [PDF]

				M. C. Gulliford, J. Charlton, and R. Latinovic Increased Utilization of Primary Care 5 Years Before Diagnosis of Type 2 Diabetes: A matched cohort study Diabetes Care, January 1, 2005; 28(1): 47 - 52. [Abstract] [Full Text] [PDF]

				A. Arredondo and A. Zuniga Economic Consequences of Epidemiological Changes in Diabetes in Middle-Income Countries: The Mexican case Diabetes Care, January 1, 2004; 27(1): 104 - 109. [Abstract] [Full Text] [PDF]

				L. E. Egede Lifestyle Modification to Improve Blood Pressure Control in Individuals With Diabetes: Is physician advice effective? Diabetes Care, March 1, 2003; 26(3): 602 - 607. [Abstract] [Full Text] [PDF]

				G. A. Nichols and J. B. Brown The Impact of Cardiovascular Disease on Medical Care Costs in Subjects With and Without Type 2 Diabetes Diabetes Care, March 1, 2002; 25(3): 482 - 486. [Abstract] [Full Text] [PDF]